MARSHALL WACE, LLP - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 174 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2019. The put-call ratio across all filers is 0.44 and the average weighting 1.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$2,934,000
-99.0%
19,406
-99.0%
0.01%
-99.0%
Q2 2022$281,021,000
-1.3%
1,928,624
-19.7%
0.58%
+7.2%
Q1 2022$284,720,000
-26.2%
2,401,284
-14.2%
0.54%
-24.3%
Q4 2021$385,657,000
+2.1%
2,798,457
+3.0%
0.71%
-54.6%
Q3 2021$377,583,000
+42.3%
2,718,185
-0.5%
1.57%
+30.7%
Q2 2021$265,259,000
+39.8%
2,732,368
-1.6%
1.20%
+37.9%
Q1 2021$189,771,000
-13.4%
2,776,467
+8.6%
0.87%
-26.7%
Q4 2020$219,121,000
+33.3%
2,556,552
+1.1%
1.19%
+12.8%
Q3 2020$164,335,000
-10.1%
2,527,850
+1.1%
1.05%
-17.9%
Q2 2020$182,880,000
+109.6%
2,501,444
-2.4%
1.28%
+47.1%
Q1 2020$87,234,000
+539.5%
2,563,443
+923.1%
0.87%
+826.6%
Q4 2019$13,640,000
-39.2%
250,562
-53.4%
0.09%
-46.6%
Q3 2019$22,437,000
+79.2%
537,797
+88.1%
0.18%
+70.9%
Q2 2019$12,522,000
+1615.3%
285,961
+1914.4%
0.10%
+3333.3%
Q1 2019$730,00014,1960.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q1 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 900,844$136,181,00079.57%
RP Management, LLC 1,111,111$167,967,00077.60%
JET CAPITAL INVESTORS L P 1,707,500$258,942,00053.95%
Alpine Global Management, LLC 373,999$56,537,00013.23%
Chicago Capital Management, LLC 154,585$23,443,00012.75%
FIFTH LANE CAPITAL, LP 140,000$21,164,00011.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3,784,482$572,100,000,00010.85%
Eversept Partners, LP 637,139$96,316,3038.35%
EQUITEC PROPRIETARY MARKETS, LLC 187,100$28,284,0007.45%
HARVEST MANAGEMENT LLC 48,503$7,332,0005.92%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders